Feeley Kevin's Insider Trades & SAST Disclosures
Feeley Kevin's most recent trade in GeneDx Holdings Corp - Ordinary Shares - Class A was a trade of 2,462 Class A Common Stock done . Disclosure was reported to the exchange on March 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Feeley Kevin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 2,462 | 6,368 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2025 | 2,462 | 17,235 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 94.72 per share. | 09 Mar 2025 | 922 | 5,446 | - | 94.7 | 87,334 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 717 | 4,034 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 717 | 4,167 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 103.94 per share. | 01 Mar 2025 | 261 | 3,906 | - | 103.9 | 27,128 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2025 | 753 | 3,225 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2025 | 753 | 3,767 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 78.48 per share. | 29 Jan 2025 | 275 | 2,950 | - | 78.5 | 21,582 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 02 Jan 2025 | 774 | 27,107 | - | 76 | 58,824 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.04 per share. | 02 Jan 2025 | 337 | 26,770 | - | 77.0 | 25,963 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 75.08 per share. | 02 Jan 2025 | 319 | 27,881 | - | 75.1 | 23,949 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 7,197 | 64,772 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 7,197 | 31,928 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.75 per share. | 16 Dec 2024 | 3,728 | 28,200 | - | 76.8 | 286,139 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 2,462 | 25,868 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 2,462 | 19,697 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.37 per share. | 09 Dec 2024 | 1,137 | 24,731 | - | 76.4 | 86,836 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 718 | 5,021 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 718 | 23,669 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 78.39 per share. | 01 Dec 2024 | 263 | 23,406 | - | 78.4 | 20,617 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 73.79 per share. | 21 Nov 2024 | 5,524 | 36,771 | - | 73.8 | 407,608 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 75.34 per share. | 21 Nov 2024 | 5,162 | 27,770 | - | 75.3 | 388,927 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 74.97 per share. | 21 Nov 2024 | 3,839 | 32,932 | - | 75.0 | 287,791 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 76.41 per share. | 21 Nov 2024 | 2,711 | 25,059 | - | 76.4 | 207,149 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 77.40 per share. | 21 Nov 2024 | 2,108 | 22,951 | - | 77.4 | 163,166 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 73.00 per share. | 21 Nov 2024 | 1,057 | 42,295 | - | 73.0 | 77,162 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 71.86 per share. | 21 Nov 2024 | 969 | 43,352 | - | 71.9 | 69,629 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 70.84 per share. | 21 Nov 2024 | 430 | 44,321 | - | 70.8 | 30,463 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 69.58 per share. | 21 Nov 2024 | 200 | 44,751 | - | 69.6 | 13,915 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2024 | 753 | 4,520 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2024 | 753 | 45,225 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 66.60 per share. | 29 Oct 2024 | 274 | 44,951 | - | 66.6 | 18,248 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 7,197 | 71,969 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 7,197 | 47,107 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 16 Sep 2024 | 2,635 | 44,472 | - | 37.6 | 99,050 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 2,462 | 22,159 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 2,462 | 40,805 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 09 Sep 2024 | 895 | 39,910 | - | 33.3 | 29,830 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 717 | 5,739 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 717 | 38,605 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 31.71 per share. | 01 Sep 2024 | 262 | 38,343 | - | 31.7 | 8,308 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 753 | 5,273 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 753 | 38,162 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.54 per share. | 29 Jul 2024 | 274 | 37,888 | - | 33.5 | 9,190 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 7,197 | 40,055 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 7,197 | 79,166 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.31 per share. | 16 Jun 2024 | 2,646 | 37,409 | - | 28.3 | 74,908 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2024 | 2,462 | 24,621 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2024 | 2,462 | 33,753 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.92 per share. | 09 Jun 2024 | 895 | 32,858 | - | 24.9 | 22,303 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 717 | 6,456 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 717 | 31,553 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 20.55 per share. | 01 Jun 2024 | 262 | 31,291 | - | 20.5 | 5,384 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 3,013 | 31,940 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 3,013 | 6,026 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 11.04 per share. | 29 Apr 2024 | 1,104 | 30,836 | - | 11.0 | 12,185 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2024 | 7,197 | 86,363 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2024 | 7,197 | 32,180 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 10.59 per share. | 16 Mar 2024 | 3,253 | 28,927 | - | 10.6 | 34,455 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.21 per share. | 12 Mar 2024 | 931 | 24,983 | - | 9.2 | 8,574 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 2,462 | 27,083 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2024 | 2,462 | 25,914 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 718 | 23,753 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 718 | 7,173 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 01 Mar 2024 | 301 | 23,452 | - | 8.6 | 2,580 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 7,197 | 25,983 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2023 | 7,197 | 93,560 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.16 per share. | 16 Dec 2023 | 2,948 | 23,035 | - | 2.2 | 6,366 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 2,462 | 29,545 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 2,462 | 19,694 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.61 per share. | 09 Dec 2023 | 908 | 18,786 | - | 1.6 | 1,462 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 717 | 17,502 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 717 | 7,891 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Feeley Kevin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.77 per share. | 01 Dec 2023 | 270 | 17,232 | - | 1.8 | 478 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 7,197 | 107,954 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 7,197 | 13,068 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.37 per share. | 16 Jun 2023 | 2,637 | 10,431 | - | 6.4 | 16,798 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 16 Jun 2023 | 107 | 10,324 | - | 6.3 | 675 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 2,462 | 34,469 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 2,462 | 6,774 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.49 per share. | 09 Jun 2023 | 903 | 5,871 | - | 6.5 | 5,860 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 718 | 4,575 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 718 | 9,325 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 01 Jun 2023 | 263 | 4,312 | - | 7 | 1,841 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 16 May 2023 | 1,516 | 3,856 | - | 6.5 | 9,852 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 99,432 | 298,295 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 99,432 | 177,292 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 3,800,000 | 3,800,000 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 81,250 | 1,218,750 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2023 | 81,250 | 109,736 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.36 per share. | 09 Mar 2023 | 31,876 | 77,860 | - | 0.4 | 11,469 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 23,674 | 331,439 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 23,674 | 38,883 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.45 per share. | 01 Mar 2023 | 10,397 | 28,486 | - | 0.4 | 4,662 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 1,300,000 | 1,300,000 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 23,674 | 355,113 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 23,674 | 23,674 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.40 per share. | 01 Dec 2022 | 8,465 | 15,209 | - | 0.4 | 3,361 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 657,617 | 657,617 | - | - | Employee Stock Option (right to buy) | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 378,787 | 378,787 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges